Andrew I. Koven

Insider Reports History

Entity
Individual
Location
3 Columbus Circle, Suite 1710, C/O Aralez Pharmaceuticals Inc., New York, NY
Signature
/s/ Mary Reumuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew I. Koven:

Stock Role Class Num Shares Value Price $ Report Date Ownership
KALA BIO, Inc. Director Common Stock 13.9K $84.8K $6.09 Jun 11, 2024 Direct
NeuroBo Pharmaceuticals, Inc. Director Common Stock 17.6K $54.9K $3.13 Jun 7, 2024 Direct
KALA BIO, Inc. Director Stock Option (right to buy) 3.9K Jun 11, 2024 Direct

Insider Reports Filed by Andrew I. Koven

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KALA KALA BIO, Inc. Jun 11, 2024 2 $0 4 Jun 12, 2024 Director
NRBO NeuroBo Pharmaceuticals, Inc. Jun 7, 2024 1 $0 4 Jun 7, 2024 Director
NRBO NeuroBo Pharmaceuticals, Inc. Jul 27, 2023 2 $0 4 Jul 28, 2023 Director
KALA Kala Pharmaceuticals, Inc. Jun 22, 2023 4 $0 4 Jun 23, 2023 Director
KALA Kala Pharmaceuticals, Inc. May 31, 2023 5 $0 4 Jun 2, 2023 Director
KALA Kala Pharmaceuticals, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
NRBO NeuroBo Pharmaceuticals, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
NRBO NeuroBo Pharmaceuticals, Inc. Sep 2, 2021 1 $0 4 Sep 3, 2021 Director
NRBO NeuroBo Pharmaceuticals, Inc. Jul 9, 2021 0 $0 3 Jul 19, 2021 Director
KALA Kala Pharmaceuticals, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director